{"date":"2026-01-19","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7850-2026-01-19-1755-ps7z81","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"17:55:31","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-01-19 17:55，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-01-19-1751-qrsqda","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"17:51:54","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-01-19 17:51，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-01-19-1711-1ym3igz","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"17:11:42","subject":"公告本公司115年第一次股東臨時會全面改選董事(含獨立董事)暨三分之一以上董事之變動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-01-19 17:11，「公告本公司115年第一次股東臨時會全面改選董事(含獨立董事)暨三分之一以上董事之變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-01-19-1710-1ux3nj","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"17:10:29","subject":"公告本公司設置審計委員會及第一屆審計委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-01-19 17:10，「公告本公司設置審計委員會及第一屆審計委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-01-19-1709-s0kpz3","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"17:09:54","subject":"公告本公司董事會推選董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-01-19 17:09，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-01-19-1702-z9jcl9","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"17:02:04","subject":"公告本公司115年第一次股東臨時會決議解除董事競業禁止案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-01-19 17:02，「公告本公司115年第一次股東臨時會決議解除董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-01-19-1701-l0uvpa","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"17:01:39","subject":"公告本公司115年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-01-19 17:01，「公告本公司115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-01-19-1701-hurcou","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-01-19","time":"17:01:12","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-01-19","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-01-19 17:01，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-01-19-1534-1yibx74","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"15:34:10","subject":"公告本公司與策略合作夥伴簽訂策略聯盟合作約定書","clause":"第8款","fact_date":"2026-01-19","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-01-19 15:34，「公告本公司與策略合作夥伴簽訂策略聯盟合作約定書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-01-19-1531-14d70in","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-01-19","time":"15:31:25","subject":"公告本公司武倍威剛口溶錠50毫克已獲衛生福利部食品藥物管理署核准並取得藥品許可證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-01-19 15:31，「公告本公司武倍威剛口溶錠50毫克已獲衛生福利部食品藥物管理署核准並取得藥品許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-01-19-1203-1fqkmsr","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-01-19","time":"12:03:08","subject":"澄清媒體報導","clause":"第51款","fact_date":"2026-01-19","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-01-19 12:03，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}